2012, Number 4
<< Back Next >>
Dermatología Cosmética, Médica y Quirúrgica 2012; 10 (4)
Cardiovascular risk in psoriasis. Framinghan risk scale and new biomarkers as predictor of cardiovascular mortality in psoriatic patients
Espinoza HCJ, Kresch TN, Vega MME, Lacy NRM, Lacy NMC, Springall VR, Bojalil PR
Language: Spanish
References: 6
Page: 301
PDF size: 82.10 Kb.
Text Extraction
No abstract
REFERENCES
Kremers HM, McEvoy MT, Dann FJ, Gabriel SE. „Heart disease in psoriasis”. J Am Acad Dermatol 2007;57:347-354.
Hensler T, Christophers E. “Disease concomitance in psoriasis”. J Am Acad Dermatol 1995;32:982-986.
Shaphiro J, Cohen AD, David M, Hodak E, Chodik G, Viner A, et al. “The association between psoriasis, diabetes mellitus, and atherosclerosis in Israel: a case-control study”. J Am Acad Dermatol 2007;56:629-634.
Ludwing R, Herzog C, Rostock A. “Psoriasis: a possible risk factor for development of coronary artery calcification”. Br J Dermatol 2007; 156:271-276.
Kaye J, Li L, Jick S. “Incidence of risk factors for myocardial infarction and other vascular diseases in patients with psoriasis”. Br J Dermatol 2008;159:895-902.
Späh F. “Inflammation in atherosclerosis and psoriasis: common pathogenic mechanisms and the potential for an integrated treatment approach”. Br J Dermatol 2008;159:10-17.
Full text